Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Retrotope initiates phase II study of RT-001 in progressive supranuclear palsy

July 1, 2021

Tissue factor knockout human placenta adherent stromal cells tested in MS model

July 1, 2021

Janssen Pharmaceutica identifies new N-acetyl-beta-D-glucosaminidase inhibitors

July 1, 2021

SwanBio begins natural history study of adrenomyeloneuropathy to support SBT-101 development

July 1, 2021

Saniona begins phase I trial of SAN-711 for neuropathic disorders

June 30, 2021

Positive phase Ib data reported for CVL-231 in patients with schizophrenia

June 30, 2021

Cybin reports preclinical data on deuteration modifications in psychedelic molecules

June 30, 2021

Q-State reports preclinical proof-of-concept data for QSB-490 in spastic paraplegia type 49

June 29, 2021

Human placenta-derived exosomes for the treatment of ischemia

June 29, 2021

LDL receptor overexpression affects tauopathy in Alzheimer's model

June 29, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...